• Evolution of Virus inactivation methods in manufacture of biologics

  • By: DD ENTERPRISES
  • Podcast

Evolution of Virus inactivation methods in manufacture of biologics

By: DD ENTERPRISES
Listen for free

  • Summary

  • Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses. DNA-based herpesviruses and RNA-based retroviruses are examples of enveloped viruses; DNA-based adenoviruses and RNA-based parvoviruses are examples of nonenveloped viruses.


    Visit Site>> Click Here
    Copyright 2024 DD ENTERPRISES
    Show More Show Less
Social Sciences
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Evolution of Virus inactivation methods in manufacture of biologics

    Evolution of Virus inactivation methods in manufacture of biologics
    May 29 2024

    Viral contamination is a common threat to all animal- and human-derived biopharmaceuticals. A virus is essentially an infectious agent that is capable of infecting a host cell and to copy itself. Viruses consist of nucleic acid (DNA or RNA) in a protein coat/capsid. Those with an outer lipid layer are referred to as enveloped viruses; those without one are classified as nonenveloped or naked viruses.


    Visit Site>> Click Here
    Show More Show Less
    19 mins

What listeners say about Evolution of Virus inactivation methods in manufacture of biologics

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available